Home

Заглавие Заеми с пари Производител thomas h pedersen nmd pharma странен Отговорно лице предприемач

Thomas Holm Pedersen - Crunchbase Person Profile
Thomas Holm Pedersen - Crunchbase Person Profile

Thomas H. Pedersen - CEO at NMD Pharma | The Org
Thomas H. Pedersen - CEO at NMD Pharma | The Org

Thomas Holm Pedersen - Chief Executive Officer, Associate professor of  Physiology and Biophysics in Aarhus, Arhus, Denmark | eMedEvents
Thomas Holm Pedersen - Chief Executive Officer, Associate professor of Physiology and Biophysics in Aarhus, Arhus, Denmark | eMedEvents

Management — NMD Pharma
Management — NMD Pharma

NMD Pharma
NMD Pharma

Company Presentation
Company Presentation

Parallel Imports of Pharmaceuticals: Evidence from Scandinavia and Policy  Proposals for Switzerland - PDF Free Download
Parallel Imports of Pharmaceuticals: Evidence from Scandinavia and Policy Proposals for Switzerland - PDF Free Download

Management — NMD Pharma
Management — NMD Pharma

Management — NMD Pharma
Management — NMD Pharma

Management — NMD Pharma
Management — NMD Pharma

R3: Reviews, Responses & Reflections in Neuroscience by utneuro - issuu
R3: Reviews, Responses & Reflections in Neuroscience by utneuro - issuu

Company Presentation
Company Presentation

NMD Pharma
NMD Pharma

Annual Report 2019 by Lundbeckfonden - issuu
Annual Report 2019 by Lundbeckfonden - issuu

PDF) Consensus Statement on Perioperative Use of Neuromuscular Monitoring
PDF) Consensus Statement on Perioperative Use of Neuromuscular Monitoring

Management — NMD Pharma
Management — NMD Pharma

Annual Report 2017 by Lundbeckfonden - issuu
Annual Report 2017 by Lundbeckfonden - issuu

Company Presentation
Company Presentation

Company Presentation
Company Presentation

65% 460 175+ 150+
65% 460 175+ 150+

Redalyc.Endocrine disruptors: strategies for determination and occurrence  in marine environments
Redalyc.Endocrine disruptors: strategies for determination and occurrence in marine environments

Management — NMD Pharma
Management — NMD Pharma

Rare Neuromuscular Disease Company NMD Pharma Raises USD 3 Million in Seed  Financing Round - Lundbeckfonden
Rare Neuromuscular Disease Company NMD Pharma Raises USD 3 Million in Seed Financing Round - Lundbeckfonden

PDF) CIC-1 chloride channels: State-of-the-art research and future  challenges
PDF) CIC-1 chloride channels: State-of-the-art research and future challenges